Palatin Technologies Stock Price - PTN

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last: $ 0.89 ▲ 0.01 (1.36%)
Company Name Stock Ticker Symbol Market Type
Palatin Technologies Inc New PTN AMEX Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.0317 -3.48% 0.8781 0.925 0.87 0.91 0.9098 23:59:55
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,910 942,054 $ 0.893153 $ 841,399 1,387,540 0.59 - 2.21
Last Trade Time Type Quantity Stock Price Currency
19:59:47 45,743 $ 0.8781 USD

Palatin Technologies Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 189.28M 215.56M $ 24.70M 0.12 - 200.25M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
23.25M $ - 0.00% - -

more financials information »

Palatin Technologies News

Loading Messages....

Latest PTN Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PTN Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week0.880.96960.870.9188809k-0.0019-0.22%
1 Month0.9540.96960.770.90461M-0.0759-7.96%
3 Months1.292.210.771.15733M-0.4119-31.93%
6 Months0.852.210.771.20953M0.02813.31%
1 Year12.210.591.11812M-0.1219-12.19%
3 Years0.52012.210.28510.83872M0.35868.83%
5 Years0.9252.210.28510.84361M-0.0469-5.07%

Palatin Technologies Description

Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction.

Your Recent History
Palatin Te..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.